Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | RECQL | P46063 | 1/20 | 0.71 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.63 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.63 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.63 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.63 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | HTR1B | P28222 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL97259 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1006073 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL97415 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1006824 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1006520 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1007090 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1006943 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1007517 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1004974 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 | |
| SCHEMBL1007291 | 1.00 | KCNA3 (0.73) | KCNA3ALDH1A1RECQLHDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197650-A1 | COPOLYMERS AND METHODS OF MAKING AND USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2025-06-19 | — | — | US | disclosed |
| EP-4460529-A1 | COPOLYMERS AND METHODS OF MAKING AND USING THE SAME | 3M Innovative Properties Company (US) | 2024-11-13 | — | — | EP | disclosed |
| WO-2023180931-A1 | COPOLYMERS AND METHODS OF MAKING AND USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-2387592-B1 | FUNCTIONALIZATION OF POLYOLEFINS WITH PHENOXY DERIVATIVES | THE UNIV OF SOUTHERN MISSISSIPPI (US) | 2018-08-29 | — | — | EP | disclosed |
| US-9650449-B2 | Functionalization of polyolefins with phenoxy derivatives | THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2017-05-16 | — | — | US | disclosed |
| US-9650449-B2 | Functionalization of polyolefins with phenoxy derivatives | THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2017-05-16 | — | — | US | disclosed |
| EP-2580252-B1 | METHODS FOR PRODUCING TELECHELIC POLYOLEFINS FROM TERPENE INITIATORS | CHEVRON ORONITE CO (US) | 2016-11-09 | — | — | EP | disclosed |
| US-9187581-B2 | Methods for producing telechelic polyolefins from terpene initiators | CHEVRON ORONITE COMPANY LLC (US) | 2015-11-17 | — | — | US | disclosed |
| US-8969484-B2 | Methods of producing mono- and multi-functional polymers from terpene-based initiators | CHEVRON ORONITE COMPANY LLC (US) | 2015-03-03 | — | — | US | disclosed |
| EP-2268606-B1 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2014-08-06 | — | — | EP | disclosed |
| US-20090312315-A1 | PAI-1 INHIBITOR | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2009-12-17 | — | — | US | disclosed |
| WO-2009132978-A1 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-11-05 | — | — | WO | disclosed |
| US-20090270505-A1 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES | HOFFMANN-LA ROCHE, INC. | 2009-10-29 | — | — | US | disclosed |
| US-7550201-B2 | Lanthanide (III)—doped nanoparticles and their applications | UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION (CA) | 2009-06-23 | — | — | US | disclosed |
| US-5952316-A | FOR TREATING AUTOIMMUNE DISEASES, E.G., RHEUMATIOD ARTHRITIS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| EP-0627406-B1 | 2-AMINO-1,3-PROPANEDIOL COMPOUND AND IMMUNOSUPPRESSANT | YOSHITOMI PHARMACEUTICAL (JP) | 1998-10-28 | — | — | EP | disclosed |
| US-5719176-A | 2-amino-1,3-propanediol compound and immunosuppressant | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-02-17 | — | — | US | disclosed |
| US-5604229-A | 2-amino-1,3-propanediol compound and immunosuppressant | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-02-18 | — | — | US | disclosed |
| EP-0627406-A1 | 2-AMINO-1,3-PROPANEDIOL COMPOUND AND IMMUNOSUPPRESSANT | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1994-12-07 | — | — | EP | disclosed |
| US-4182776-A | Method of treating lipidemia with aryloxyalkylaminobenzoic acids and esters | AMERICAN CYANAMID COMPANY (US) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270505-A1 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES | CPT1B, CPT1A, CPT2 | KCNA3 3178/4885ALDH1A1 177/4885RECQL 3287/4885 |
| US-20090312315-A1 | PAI-1 INHIBITOR | SERPINC1, SERPINE1, SERPINH1 | KCNA3 3709/4885ALDH1A1 1168/4885RECQL 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.